Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125969211 | 12596921 | 1 | I | 20150209 | 20160719 | 20160727 | 20160727 | EXP | PHHY2016DE100410 | NOVARTIS | 0.00 | E | F | Y | 0.00000 | 20160727 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125969211 | 12596921 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Unknown | 10 MG, UNK | 22334 | 10 | MG | TABLET | |||||||
| 125969211 | 12596921 | 2 | SS | LETROZOLE. | LETROZOLE | 1 | Unknown | 2.5 MG, UNK | 0 | 2.5 | MG | ||||||||
| 125969211 | 12596921 | 3 | SS | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | UNK | U | 0 | |||||||||
| 125969211 | 12596921 | 4 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125969211 | 12596921 | 5 | SS | FASLODEX | FULVESTRANT | 1 | Unknown | UNK | U | 0 | |||||||||
| 125969211 | 12596921 | 6 | C | L-THYROXINE | LEVOTHYROXINE | 1 | Unknown | UNK | 0 | ||||||||||
| 125969211 | 12596921 | 7 | C | SIMVA | 2 | Unknown | 10 OT, UNK | 0 | |||||||||||
| 125969211 | 12596921 | 8 | C | ASA | ASPIRIN | 1 | Unknown | 100 OT, UNK | 0 | ||||||||||
| 125969211 | 12596921 | 9 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | UNK | 0 | ||||||||||
| 125969211 | 12596921 | 10 | C | EXFORGE HCT | AMLODIPINE BESYLATEHYDROCHLOROTHIAZIDEVALSARTAN | 1 | Unknown | UNK | 0 | ||||||||||
| 125969211 | 12596921 | 11 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK | 0 | ||||||||||
| 125969211 | 12596921 | 12 | C | VALSARTAN. | VALSARTAN | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125969211 | 12596921 | 1 | Product used for unknown indication |
| 125969211 | 12596921 | 2 | Product used for unknown indication |
| 125969211 | 12596921 | 3 | Product used for unknown indication |
| 125969211 | 12596921 | 4 | Product used for unknown indication |
| 125969211 | 12596921 | 5 | Product used for unknown indication |
| 125969211 | 12596921 | 6 | Hypothyroidism |
| 125969211 | 12596921 | 7 | Hypercholesterolaemia |
| 125969211 | 12596921 | 8 | Haemodilution |
| 125969211 | 12596921 | 9 | Hypertension |
| 125969211 | 12596921 | 10 | Hypertension |
| 125969211 | 12596921 | 11 | Hypertension |
| 125969211 | 12596921 | 12 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125969211 | 12596921 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125969211 | 12596921 | Alopecia | |
| 125969211 | 12596921 | Dry eye | |
| 125969211 | 12596921 | Polyneuropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125969211 | 12596921 | 1 | 201208 | 201402 | 0 | |
| 125969211 | 12596921 | 2 | 200603 | 201005 | 0 |